Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220019046 220013504 1.83 62 Curative (C) 2014-05-25 2014-10-26 AML 19 TRIAL 01 N 220024501 AML19 TRIAL
220019047 220013510 1.62 120 Palliative (P) 2015-04-28 2015-05-03 AML 19 TRIAL 1 N 220024525 AML19 TRIAL
220019048 220013511 1.88 88 Curative (C) 2015-12-21 2016-01-01 AML 19 TRIAL 01 N 220024527 AML19 TRIAL
220019049 220006455 1.62 71 Curative (C) 2017-06-30 2017-07-05 AML 19 TRIAL 1 null 220024528 AML19 TRIAL
220019050 220006457 0 72.2 Curative (C) 2018-06-02 2018-06-04 AML 19 TRIAL N N 220024534 AML19 TRIAL
220019051 220013516 1.57 81 Curative (C) 2014-04-17 2014-10-24 Trial Unspecified 01 N 220024538 TRIAL
220019052 220006461 1.58 54.1 Curative (C) 2017-02-13 2017-02-13 AML 19 TRIAL N N 220024547 AML19 TRIAL
220019053 220013519 1.7 60 Curative (C) 2013-11-13 2013-12-31 Trial Unspecified Y null 220024548 TRIAL
220019054 220017380 1.64 78 Curative (C) 2014-11-23 2015-07-20 Trial Unspecified N N 220024554 TRIAL
220019055 220021843 1.67 53.9 Curative (C) 2017-10-04 2017-10-09 AML 19 TRIAL Y Y 220024560 AML19 TRIAL
220019056 220006467 1.6 52.4 Curative (C) 2017-09-14 2018-03-07 AML 19 TRIAL null N 220024598 AML19 TRIAL
220019057 220013525 1.96 75.2 Disease modification (D) 2017-02-06 2017-03-12 AML 19 TRIAL Y null 220024615 AML19 TRIAL
220019058 220006477 1.68 59.5 Disease modification (D) 2017-07-02 2017-12-17 Trial Unspecified Y null 220024639 TRIAL
220019059 220006481 1.69 72.3 Disease modification (D) 2013-11-28 2013-11-28 AML 19 TRIAL Y N 220024664 AML19 TRIAL
220019061 220006486 1.55 73.5 Curative (C) 2013-11-24 2013-11-27 AML 19 TRIAL Y N 220024673 AML19 TRIAL
220019062 220006488 1.73 54.1 Curative (C) 2015-10-08 2015-10-15 AML 19 TRIAL 1 N 220024674 AML19 TRIAL
220019063 220006491 1.7 0 Curative (C) 2015-02-25 2015-02-25 Trial Unspecified Y N 220024676 TRIAL
220019065 220006496 1.81 94.6 Not known (9) 2018-09-20 2018-09-20 Trial Unspecified Y N 220024687 TRIAL
220019066 220006497 1.8 90.9 Curative (C) 2014-04-28 2014-06-05 AML 19 TRIAL N N 220024689 AML19 TRIAL
220019067 220013542 1.62 72 Disease modification (D) 2018-01-22 2018-06-01 AML 19 TRIAL 1 N 220024693 AML19 TRIAL
220019068 220021451 1.65 0 Disease modification (D) 2018-09-03 2018-12-24 Trial Unspecified null N 220024701 TRIAL
220019070 220013546 1.69 99.9 Curative (C) 2014-06-21 2014-06-21 AML 19 TRIAL N N 220024761 AML19 TRIAL
220019071 220013548 1.66 65.3 Palliative (P) 2016-05-06 2016-05-10 Trial Unspecified 1 N 220024764 TRIAL
220019072 220006509 null 58.5 Curative (C) 2014-03-23 2014-03-23 Trial Unspecified 1 N 220024778 TRIAL
220019073 220006511 1.65 71.8 Palliative (P) 2016-06-14 2016-06-15 Trial Unspecified N N 220024783 TRIAL
220019074 220006513 1.55 57.6 Not known (9) 2013-06-25 2013-08-29 Trial Unspecified N N 220024790 TRIAL
220019075 220006515 1.82 123.8 Curative (C) 2016-01-06 2016-04-10 Trial Unspecified 01 N 220024800 TRIAL
220019076 220006517 1.76 70.2 Curative (C) 2017-07-06 2017-08-24 AML 19 TRIAL N null 220024802 AML19 TRIAL
220019077 220006518 null 69.3 Curative (C) 2013-02-03 2013-02-03 AML 19 TRIAL Y N 220024810 AML19 TRIAL
220019078 220021452 1.73 92.5 Curative (C) 2016-09-17 2016-12-14 Trial Unspecified 02 N 220024810 TRIAL
220019081 220013560 1.78 77.3 Curative (C) 2015-08-20 2015-08-20 Trial Unspecified Y null 220024843 TRIAL
220019082 220022074 1.67 68.1 Curative (C) 2015-03-08 2015-03-08 Trial Unspecified N N 220024847 TRIAL
220019083 220022340 1.83 95.6 Curative (C) 2017-07-12 2017-07-16 Trial Unspecified Y null 220024847 TRIAL
220019084 220006525 1.66 87.9 Disease modification (D) 2015-01-20 2015-05-07 AML 19 TRIAL Y N 220024870 AML19 TRIAL
220019085 220006529 1.6 89.2 Curative (C) 2015-03-03 2015-03-03 Trial Unspecified N null 220024897 TRIAL
220019086 220020773 1.72 88 Curative (C) 2014-11-26 2014-11-26 Trial Unspecified N null 220024903 TRIAL
220019087 220017403 1.73 90.1 Curative (C) 2018-03-14 2018-03-14 AML 19 TRIAL 01 null 220024911 AML19 TRIAL
220019088 220022324 1.59 59.2 Curative (C) 2017-12-10 2018-03-06 AML 19 TRIAL N N 220024925 AML19 TRIAL
220019089 220013568 1.66 null Curative (C) 2014-01-07 2014-04-27 Trial Unspecified Y N 220024981 TRIAL
220019091 220013572 1.9 91.2 Palliative (P) 2015-06-10 2015-06-10 Trial Unspecified 1 N 220025004 TRIAL
220019094 220013576 1.56 62.9 Curative (C) 2016-12-06 2016-12-09 AML 19 TRIAL Y N 220025045 AML19 TRIAL
220019095 220017410 1.59 50.4 Curative (C) 2017-04-27 2017-04-27 AML 19 TRIAL N N 220025047 AML19 TRIAL
220019096 220013578 null 71.4 Curative (C) 2013-09-13 2013-09-24 Trial Unspecified Y N 220025054 TRIAL
220019097 220006555 1.7 66.1 Palliative (P) 2017-10-16 2017-11-27 Trial Unspecified 2 N 220025062 TRIAL
220019098 220006558 null null Curative (C) 2016-08-14 2016-10-27 Hydroxycarbamide N N 220025077 HYDROXYCARBAMIDE
220019099 220017414 1.57 59.3 Curative (C) 2017-10-21 2017-10-21 CYTARABINE N N 220025109 CYTARABINE
220019100 220013585 1.81 61.2 Palliative (P) 2016-04-29 2016-06-14 AML Interim Guidelines FLA -Ida 02 N 220025121 NOT MATCHED
220019101 220006569 null 62 Palliative (P) 2016-09-02 2016-09-04 Cytarabine low (10to20mg/m2) IV/SC null null 220025135 CYTARABINE
220019102 220017416 1.73 null null 2016-10-26 2016-12-06 Cytarabine Low Dose N null 220025143 CYTARABINE
220019103 220006573 null 61.2 Curative (C) 2014-01-03 2014-02-14 AML MyeChild 02 null 220025154 NOT MATCHED